Transcript analysis of CFTR nonsense mutations in lymphocytes and nasal epithelial cells from cystic fibrosis patients

Human Mutation
K WillJ Schmidtke

Abstract

The mutational effects at the mRNA level were investigated by RT-PCR analysis of nine different nonsense mutations (Q39X, E60X, R75X, G542X, L719X, Y1092X, R1162X, S1196X, W1282X) and one frameshift mutation (1078delT) within the CFTR gene. With the exception of mutation R1162X, reduced mRNA levels ranging from 30% to less than 5% of the wild type have been observed. In case of the R75X and E60X mutations, the mRNA reduction was accompanied by the appearance of atypical CFTR isoforms. Single exon 3 skipping, as well as joint exon 2 and 3 skipping, was observed in lymphocyte and nasal epithelial mRNA derived from R75X alleles. The analysis of mRNA transcribed from E60X alleles revealed skipping of exon 3 (lymphocytes and nasal epithelial cells) or skipping of exons 3 and 4 (nasal epithelial cells). With the exception of the E60X mutation, no obvious tissue-specific differences in the splicing pattern and ratios of mutation to wild-type transcripts were detected between lymphocytes and nasal epithelial cells. In addition to aberrant splicing, the reduction of transcripts is the most common effect of nonsense and frameshift mutations within the CFTR gene.

References

Jul 1, 1992·Human Molecular Genetics·N FonknechtenJ C Kaplan
Feb 5, 1992·Journal of Molecular Biology·L H ZhangD Jenssen
Aug 10, 1990·Cell·J F AtkinsR F Gesteland
Nov 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·B S KeremJ M Rommens
Nov 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·R W BondD I Gottlieb
Jul 1, 1989·Molecular and Cellular Biology·G UrlaubL A Chasin
Apr 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·S J Baserga, E J Benz
Jan 1, 1993·Human Mutation·F SangiuoloB Dallapiccola
Jun 1, 1993·Human Molecular Genetics·R A GibsonC G Mathew
Jan 1, 1993·Human Molecular Genetics·J A NaylorF Giannelli

❮ Previous
Next ❯

Citations

Nov 7, 1998·Mutation Research·C R Valentine
Sep 27, 2000·Clinical Genetics·P M FrossardK P Dawson
Dec 2, 2000·Current Opinion in Pulmonary Medicine·L R Choo-Kang, P L Zeitlin
Jul 23, 2005·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Ana Carina da PaulaMargarida D Amaral
Oct 25, 2002·American Journal of Respiratory Cell and Molecular Biology·Anabela S RamalhoMargarida D Amaral
Sep 29, 2015·The Journal of Thoracic and Cardiovascular Surgery·Don HayesHeidi M Mansour
Mar 19, 2014·The International Journal of Biochemistry & Cell Biology·Pascale FanenAlexandre Hinzpeter
Jun 15, 2016·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Don HayesDmitry Tumin
Jul 6, 2016·The Lancet. Respiratory Medicine·Frauke Stanke, Burkhard Tümmler
May 23, 2000·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·A ClaassB Tümmler
Jan 24, 1998·Clinical Genetics·M StuhrmannJ Schmidtke
Aug 23, 2002·Journal of the American Society of Nephrology : JASN·Olivier Bonny, Bernard C Rossier
Nov 6, 2018·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·A BergougnouxM Taulan-Cadars
Dec 21, 2020·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Natacha MartinAlexandre Hinzpeter
Feb 26, 2019·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·M A AksitN Sharma

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.